Login / Signup

TREM2 as a Potential Immune-Related Biomarker of Prognosis in Patients with Skin Cutaneous Melanoma Microenvironment.

Xinlin ZhuZhaoxiang ZengMin ChenXianzhen ChenDongying HuWeiwei JiangMingwei DuTianyang ChenTiancheng ChenWanqing LiaoChao ZhangYing QuWei-Hua Pan
Published in: Disease markers (2023)
TREM2 played a crucial role in SKCM, which might be a prognostic biomarker and correlated with immune infifiltrates in SKCM patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • stem cells
  • prognostic factors
  • risk assessment
  • patient reported outcomes
  • climate change
  • skin cancer